| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8668414 | Journal of Clinical Lipidology | 2018 | 16 Pages |
Abstract
Twenty-four-week treatment of CoQ10 ameliorates multiple CVD risk factors. The versatility and safety of CoQ10 makes it a potential candidate for the primary prevention of CVD.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peiwen Zhang, Chen MD, Honghui MD, PhD, Jiaji Wang, Shengqiang Lin, Huamei Li, Yan MD, PhD, Wenhua MD, PhD,